{
    "medicine_id": "47c02b64c55dc588a64d2f1a3dd5aff120658aaa",
    "platform_id": "DB00054",
    "metadata": {
        "name": "Reopro 2 mg 1mL Injection solution",
        "composition": "2 mg 1mL Abciximab",
        "clinical_particulars": {
            "therapeutic_indications": "Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention and in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours Abciximab is intended for use with aspirin and heparin and has been studied only in that setting",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Abciximab inhibits platelet aggregation by preventing the binding of fibrinogen von Willebrand factor and other adhesive molecules to GPIIb IIIa receptor sites on activated platelets A single intravenous bolus dose from 0 15 mg kg to 0 30 mg kg produced rapid dose dependent inhibition of platelet function After two hours post injection with a dose of 0 25 0 30 mg kg 80 of the GPIIb IIIa receptors were blocked and platelet aggregation was prevented GPIIb IIIa is the major surface receptor involved in the final pathway of platelet aggregation Bleeding time increases to over 30 minutes at the aforementioned doses To compare baseline values were five minutes",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06605",
                        "description": "Apixaban may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Dabigatran etexilate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Abciximab is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Edoxaban is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Abciximab may increase the anticoagulant activities of Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06206",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Abciximab is combined with Sugammadex"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "Urokinase may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Aprotinin"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Glycochenodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Cholic Acid"
                    },
                    {
                        "drugbank-id": "DB02691",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Glycocholic acid"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Deoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Taurocholic acid"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Obeticholic acid"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Chenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08833",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08834",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08857",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bamet UD2"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB11789",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Hyodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB01296",
                        "description": "Glucosamine may increase the antiplatelet activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ibritumomab tiuxetan"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Tipranavir may increase the antiplatelet activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "Vitamin E may increase the antiplatelet activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The therapeutic efficacy of Abciximab can be increased when used in combination with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of bleeding can be increased when Ifosfamide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The therapeutic efficacy of Abciximab can be increased when used in combination with Quinine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of bleeding can be increased when Tamoxifen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of bleeding can be increased when Toremifene is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The therapeutic efficacy of Abciximab can be increased when used in combination with Pentoxifylline"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "The therapeutic efficacy of Abciximab can be increased when used in combination with Levocarnitine"
                    },
                    {
                        "drugbank-id": "DB00890",
                        "description": "Dienestrol may increase the thrombogenic activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB12487",
                        "description": "Promestriene may increase the thrombogenic activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Dextran may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when SC 236 is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when NS 398 is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04865",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Omacetaxine mepesuccinate"
                    },
                    {
                        "drugbank-id": "DB09211",
                        "description": "The risk or severity of adverse effects can be increased when Limaprost is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00048",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum"
                    },
                    {
                        "drugbank-id": "DB11133",
                        "description": "Omega 3 fatty acids may increase the antiplatelet activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "Carbimazole may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "Propylthiouracil may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Methimazole may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "3 5 Diiodotyrosine may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "Potassium Iodide may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "Dibromotyrosine may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Potassium perchlorate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "Methylthiouracil may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "Benzylthiouracil may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB04066",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with p Coumaric acid"
                    },
                    {
                        "drugbank-id": "DB04682",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Octylphenoxy polyethoxyethanol"
                    },
                    {
                        "drugbank-id": "DB05830",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Trestolone"
                    },
                    {
                        "drugbank-id": "DB06266",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Lonidamine"
                    },
                    {
                        "drugbank-id": "DB08867",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ulipristal"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Isosorbide"
                    },
                    {
                        "drugbank-id": "DB11507",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cloprostenol"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Triptolide"
                    },
                    {
                        "drugbank-id": "DB13044",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Gossypol"
                    },
                    {
                        "drugbank-id": "DB13310",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ormeloxifene"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "Desogestrel may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "Levonorgestrel may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00378",
                        "description": "Dydrogesterone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "Norethisterone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "Ethynodiol diacetate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "Norgestimate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "Cyproterone acetate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB06713",
                        "description": "Norelgestromin may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "Gestodene may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "Hydroxyprogesterone caproate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Dienogest may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09124",
                        "description": "Medrogestone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "Norethynodrel may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "Norgestrel may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB11372",
                        "description": "Altrenogest may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "Gestrinone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB11636",
                        "description": "Nomegestrol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "Lynestrenol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13230",
                        "description": "Gestonorone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "Chlormadinone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13533",
                        "description": "Methylestrenolone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "Norgestrienone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13602",
                        "description": "Promegestone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "Quingestanol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "Demegestone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13866",
                        "description": "Etynodiol may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "Nomegestrol acetate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB14570",
                        "description": "Hydroxyprogesterone may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB14678",
                        "description": "Norethindrone enanthate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB14679",
                        "description": "Quingestanol acetate may decrease the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "The risk or severity of bleeding can be increased when Dersalazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09543",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11079",
                        "description": "The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "The risk or severity of bleeding can be increased when Aloxiprin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The risk or severity of bleeding can be increased when Choline salicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Bivalirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Argatroban"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ardeparin"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Fondaparinux"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Dipyridamole"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Heparin"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Enoxaparin"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ximelagatran"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Defibrotide"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ancrod"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Beraprost"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Prasugrel"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Sulodexide"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Idraparinux"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Cangrelor"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Otamixaban"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Danaparoid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Dalteparin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Triflusal"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Desirudin"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Protein C"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin III human"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Letaxaban"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Darexaban"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Gabexate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of bleeding can be increased when Ticlopidine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of bleeding can be increased when Clopidogrel is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of bleeding can be increased when Tirofiban is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of bleeding can be increased when Cilostazol is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of bleeding can be increased when Sevoflurane is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of bleeding can be increased when Resveratrol is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Nimesulide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of bleeding can be increased when Tesmilifene is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of bleeding can be increased when Sarpogrelate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Nitroaspirin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of bleeding can be increased when Ketanserin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Indobufen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Edetic acid"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Troxerutin"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Carmustine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Dexrazoxane"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Pemetrexed"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB03404",
                        "description": "Hemin may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01481",
                        "description": "1 Testosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01485",
                        "description": "4 Hydroxytestosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01510",
                        "description": "Dehydrochloromethyltestosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01541",
                        "description": "Boldenone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01543",
                        "description": "18 methyl 19 nortestosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01564",
                        "description": "Calusterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01569",
                        "description": "Formebolone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01572",
                        "description": "Methyl 1 testosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB07447",
                        "description": "5beta dihydrotestosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB08619",
                        "description": "Testosterone succinate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB11429",
                        "description": "Mibolerone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Testosterone cypionate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Testosterone enanthate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13947",
                        "description": "Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13951",
                        "description": "Stanolone acetate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB13958",
                        "description": "Trestolone acetate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB14093",
                        "description": "1 2 6 7 3H Testosterone may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB14655",
                        "description": "Drostanolone propionate may increase the anticoagulant activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB11051",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Azficel T"
                    },
                    {
                        "drugbank-id": "DB09568",
                        "description": "The therapeutic efficacy of Abciximab can be increased when used in combination with Omega 3 carboxylic acids"
                    },
                    {
                        "drugbank-id": "DB00002",
                        "description": "The risk or severity of adverse effects can be increased when Cetuximab is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00028",
                        "description": "The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00043",
                        "description": "The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00057",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Indium In 111 satumomab pendetide"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Rituximab"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Basiliximab"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Muromonab"
                    },
                    {
                        "drugbank-id": "DB00076",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Digoxin Immune Fab Ovine"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00089",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Capromab pendetide"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Efalizumab"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Antithymocyte immunoglobulin rabbit"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00110",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Palivizumab"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Daclizumab"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab"
                    },
                    {
                        "drugbank-id": "DB00113",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Technetium Tc 99m arcitumomab"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Eculizumab"
                    },
                    {
                        "drugbank-id": "DB01269",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Panitumumab"
                    },
                    {
                        "drugbank-id": "DB01270",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ranibizumab"
                    },
                    {
                        "drugbank-id": "DB04901",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Galiximab"
                    },
                    {
                        "drugbank-id": "DB04949",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Pexelizumab"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB04958",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Epratuzumab"
                    },
                    {
                        "drugbank-id": "DB04962",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bectumomab"
                    },
                    {
                        "drugbank-id": "DB04964",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Oregovomab"
                    },
                    {
                        "drugbank-id": "DB04988",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with IGN311"
                    },
                    {
                        "drugbank-id": "DB05006",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Adecatumumab"
                    },
                    {
                        "drugbank-id": "DB05097",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab"
                    },
                    {
                        "drugbank-id": "DB05101",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Matuzumab"
                    },
                    {
                        "drugbank-id": "DB05111",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Fontolizumab"
                    },
                    {
                        "drugbank-id": "DB05136",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bavituximab"
                    },
                    {
                        "drugbank-id": "DB05139",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with CR002"
                    },
                    {
                        "drugbank-id": "DB05209",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Rozrolimupab"
                    },
                    {
                        "drugbank-id": "DB05304",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Girentuximab"
                    },
                    {
                        "drugbank-id": "DB05336",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Obiltoxaximab"
                    },
                    {
                        "drugbank-id": "DB05405",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with XTL 001"
                    },
                    {
                        "drugbank-id": "DB05437",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with NAV 1800"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Briakinumab"
                    },
                    {
                        "drugbank-id": "DB05496",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Otelixizumab"
                    },
                    {
                        "drugbank-id": "DB05545",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with AMG 108"
                    },
                    {
                        "drugbank-id": "DB05550",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Iratumumab"
                    },
                    {
                        "drugbank-id": "DB05555",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Enokizumab"
                    },
                    {
                        "drugbank-id": "DB05578",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ramucirumab"
                    },
                    {
                        "drugbank-id": "DB05595",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Farletuzumab"
                    },
                    {
                        "drugbank-id": "DB05656",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Veltuzumab"
                    },
                    {
                        "drugbank-id": "DB05679",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ustekinumab"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB05793",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with PRO 542"
                    },
                    {
                        "drugbank-id": "DB05797",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with TNX 901"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB05892",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with RI 624"
                    },
                    {
                        "drugbank-id": "DB05915",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with MYO 029"
                    },
                    {
                        "drugbank-id": "DB05916",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with CT 011"
                    },
                    {
                        "drugbank-id": "DB05941",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Leronlimab"
                    },
                    {
                        "drugbank-id": "DB05996",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Glembatumumab vedotin"
                    },
                    {
                        "drugbank-id": "DB06043",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Olaratumab"
                    },
                    {
                        "drugbank-id": "DB06049",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with IPH 2101"
                    },
                    {
                        "drugbank-id": "DB06050",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with TB 402"
                    },
                    {
                        "drugbank-id": "DB06101",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with IMC 1C11"
                    },
                    {
                        "drugbank-id": "DB06116",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Eldelumab"
                    },
                    {
                        "drugbank-id": "DB06162",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lumiliximab"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ipilimumab"
                    },
                    {
                        "drugbank-id": "DB06192",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Nimotuzumab"
                    },
                    {
                        "drugbank-id": "DB06241",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Clenoliximab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06304",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with BIIB015"
                    },
                    {
                        "drugbank-id": "DB06305",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sonepcizumab"
                    },
                    {
                        "drugbank-id": "DB06310",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Motavizumab"
                    },
                    {
                        "drugbank-id": "DB06317",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Elotuzumab"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06322",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Carotuximab"
                    },
                    {
                        "drugbank-id": "DB06324",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with XmAb 2513"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06343",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Teprotumumab"
                    },
                    {
                        "drugbank-id": "DB06360",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lucatumumab"
                    },
                    {
                        "drugbank-id": "DB06366",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Pertuzumab"
                    },
                    {
                        "drugbank-id": "DB06371",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Siplizumab"
                    },
                    {
                        "drugbank-id": "DB06467",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Apolizumab"
                    },
                    {
                        "drugbank-id": "DB06474",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sibrotuzumab"
                    },
                    {
                        "drugbank-id": "DB06550",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bivatuzumab"
                    },
                    {
                        "drugbank-id": "DB06557",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lerdelimumab"
                    },
                    {
                        "drugbank-id": "DB06599",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lexatumumab"
                    },
                    {
                        "drugbank-id": "DB06602",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Reslizumab"
                    },
                    {
                        "drugbank-id": "DB06606",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Teplizumab"
                    },
                    {
                        "drugbank-id": "DB06607",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Catumaxomab"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Mepolizumab"
                    },
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Denosumab"
                    },
                    {
                        "drugbank-id": "DB06647",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Volociximab"
                    },
                    {
                        "drugbank-id": "DB06650",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ofatumumab"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Belimumab"
                    },
                    {
                        "drugbank-id": "DB08902",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Raxibacumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09035",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Nivolumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB09037",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Pembrolizumab"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Anthrax immune globulin human"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09105",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Asfotase alfa"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Idarucizumab"
                    },
                    {
                        "drugbank-id": "DB09302",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Alirocumab"
                    },
                    {
                        "drugbank-id": "DB09303",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Evolocumab"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09331",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Daratumumab"
                    },
                    {
                        "drugbank-id": "DB09559",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Necitumumab"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11595",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Atezolizumab"
                    },
                    {
                        "drugbank-id": "DB11604",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tetanus Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11621",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Human Varicella Zoster Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11646",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Conatumumab"
                    },
                    {
                        "drugbank-id": "DB11657",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tabalumab"
                    },
                    {
                        "drugbank-id": "DB11680",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ficlatuzumab"
                    },
                    {
                        "drugbank-id": "DB11685",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Figitumumab"
                    },
                    {
                        "drugbank-id": "DB11714",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Durvalumab"
                    },
                    {
                        "drugbank-id": "DB11715",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bapineuzumab"
                    },
                    {
                        "drugbank-id": "DB11731",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab mafodotin"
                    },
                    {
                        "drugbank-id": "DB11746",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Onartuzumab"
                    },
                    {
                        "drugbank-id": "DB11756",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Solanezumab"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11771",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tremelimumab"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11826",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lampalizumab"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11840",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dalotuzumab"
                    },
                    {
                        "drugbank-id": "DB11849",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Emibetuzumab"
                    },
                    {
                        "drugbank-id": "DB11850",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ublituximab"
                    },
                    {
                        "drugbank-id": "DB11856",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ligelizumab"
                    },
                    {
                        "drugbank-id": "DB11857",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Seribantumab"
                    },
                    {
                        "drugbank-id": "DB11862",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Landogrozumab"
                    },
                    {
                        "drugbank-id": "DB11866",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Romosozumab"
                    },
                    {
                        "drugbank-id": "DB11884",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Vadastuximab Talirine"
                    },
                    {
                        "drugbank-id": "DB11914",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lebrikizumab"
                    },
                    {
                        "drugbank-id": "DB11930",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Varlilumab"
                    },
                    {
                        "drugbank-id": "DB11945",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Avelumab"
                    },
                    {
                        "drugbank-id": "DB11959",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Crenezumab"
                    },
                    {
                        "drugbank-id": "DB11972",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Rilotumumab"
                    },
                    {
                        "drugbank-id": "DB11976",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Anifrolumab"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ocrelizumab"
                    },
                    {
                        "drugbank-id": "DB12023",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Benralizumab"
                    },
                    {
                        "drugbank-id": "DB12034",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Gantenerumab"
                    },
                    {
                        "drugbank-id": "DB12053",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Visilizumab"
                    },
                    {
                        "drugbank-id": "DB12077",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Urelumab"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12090",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Patritumab"
                    },
                    {
                        "drugbank-id": "DB12102",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Fulranumab"
                    },
                    {
                        "drugbank-id": "DB12104",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tarextumab"
                    },
                    {
                        "drugbank-id": "DB12118",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sotatercept"
                    },
                    {
                        "drugbank-id": "DB12119",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Gevokizumab"
                    },
                    {
                        "drugbank-id": "DB12142",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Duligotuzumab"
                    },
                    {
                        "drugbank-id": "DB12152",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Simtuzumab"
                    },
                    {
                        "drugbank-id": "DB12157",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Fasinumab"
                    },
                    {
                        "drugbank-id": "DB12159",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dupilumab"
                    },
                    {
                        "drugbank-id": "DB12169",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tralokinumab"
                    },
                    {
                        "drugbank-id": "DB12189",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Etrolizumab"
                    },
                    {
                        "drugbank-id": "DB12202",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Zalutumumab"
                    },
                    {
                        "drugbank-id": "DB12205",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ganitumab"
                    },
                    {
                        "drugbank-id": "DB12213",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Etaracizumab"
                    },
                    {
                        "drugbank-id": "DB12240",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Polatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12246",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Inclacumab"
                    },
                    {
                        "drugbank-id": "DB12250",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Cixutumumab"
                    },
                    {
                        "drugbank-id": "DB12261",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ascrinvacumab"
                    },
                    {
                        "drugbank-id": "DB12274",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Aducanumab"
                    },
                    {
                        "drugbank-id": "DB12281",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Luspatercept"
                    },
                    {
                        "drugbank-id": "DB12296",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with GS 5745"
                    },
                    {
                        "drugbank-id": "DB12317",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Vanucizumab"
                    },
                    {
                        "drugbank-id": "DB12331",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12335",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tanezumab"
                    },
                    {
                        "drugbank-id": "DB12342",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ensituximab"
                    },
                    {
                        "drugbank-id": "DB12344",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Fezakinumab"
                    },
                    {
                        "drugbank-id": "DB12363",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dusigitumab"
                    },
                    {
                        "drugbank-id": "DB12396",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Fresolimumab"
                    },
                    {
                        "drugbank-id": "DB12413",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Indusatumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12456",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bococizumab"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB12498",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Mogamulizumab"
                    },
                    {
                        "drugbank-id": "DB12520",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Plozalizumab"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB12534",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Mavrilimumab"
                    },
                    {
                        "drugbank-id": "DB12560",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Blosozumab"
                    },
                    {
                        "drugbank-id": "DB12584",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bimagrumab"
                    },
                    {
                        "drugbank-id": "DB12589",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dacetuzumab"
                    },
                    {
                        "drugbank-id": "DB12609",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tovetumab"
                    },
                    {
                        "drugbank-id": "DB12683",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lumretuzumab"
                    },
                    {
                        "drugbank-id": "DB12698",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ibalizumab"
                    },
                    {
                        "drugbank-id": "DB12701",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Intetumumab"
                    },
                    {
                        "drugbank-id": "DB12718",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Carlumab"
                    },
                    {
                        "drugbank-id": "DB12734",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Demcizumab"
                    },
                    {
                        "drugbank-id": "DB12773",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sifalimumab"
                    },
                    {
                        "drugbank-id": "DB12775",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Abituzumab"
                    },
                    {
                        "drugbank-id": "DB12797",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ecromeximab"
                    },
                    {
                        "drugbank-id": "DB12807",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Naptumomab Estafenatox"
                    },
                    {
                        "drugbank-id": "DB12815",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Crotedumab"
                    },
                    {
                        "drugbank-id": "DB12820",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Concizumab"
                    },
                    {
                        "drugbank-id": "DB12826",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab"
                    },
                    {
                        "drugbank-id": "DB12844",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Rontalizumab"
                    },
                    {
                        "drugbank-id": "DB12845",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Amatuximab"
                    },
                    {
                        "drugbank-id": "DB12849",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Clazakizumab"
                    },
                    {
                        "drugbank-id": "DB12891",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ozanezumab"
                    },
                    {
                        "drugbank-id": "DB12893",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sacituzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12917",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bimekizumab"
                    },
                    {
                        "drugbank-id": "DB12943",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Milatuzumab"
                    },
                    {
                        "drugbank-id": "DB12976",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Robatumumab"
                    },
                    {
                        "drugbank-id": "DB13017",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Rovalpituzumab Tesirine"
                    },
                    {
                        "drugbank-id": "DB13037",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Namilumab"
                    },
                    {
                        "drugbank-id": "DB13045",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Racotumomab"
                    },
                    {
                        "drugbank-id": "DB13073",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tregalizumab"
                    },
                    {
                        "drugbank-id": "DB13127",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Olokizumab"
                    },
                    {
                        "drugbank-id": "DB13140",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bezlotoxumab"
                    },
                    {
                        "drugbank-id": "DB13375",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Edrecolomab"
                    },
                    {
                        "drugbank-id": "DB13535",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Nebacumab"
                    },
                    {
                        "drugbank-id": "DB13886",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Human cytomegalovirus immune globulin"
                    },
                    {
                        "drugbank-id": "DB13976",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sulesomab"
                    },
                    {
                        "drugbank-id": "DB13979",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Besilesomab"
                    },
                    {
                        "drugbank-id": "DB14004",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tildrakizumab"
                    },
                    {
                        "drugbank-id": "DB14012",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Burosumab"
                    },
                    {
                        "drugbank-id": "DB14039",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Erenumab"
                    },
                    {
                        "drugbank-id": "DB14040",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Eptinezumab"
                    },
                    {
                        "drugbank-id": "DB14041",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Fremanezumab"
                    },
                    {
                        "drugbank-id": "DB14042",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Galcanezumab"
                    },
                    {
                        "drugbank-id": "DB14211",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Fanolesomab"
                    },
                    {
                        "drugbank-id": "DB14580",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lecanemab"
                    },
                    {
                        "drugbank-id": "DB14597",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lanadelumab"
                    },
                    {
                        "drugbank-id": "DB14707",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Cemiplimab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14776",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Camrelizumab"
                    },
                    {
                        "drugbank-id": "DB14778",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Setrusumab"
                    },
                    {
                        "drugbank-id": "DB14784",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Gancotamab"
                    },
                    {
                        "drugbank-id": "DB14809",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Anetumab ravtansine"
                    },
                    {
                        "drugbank-id": "DB14811",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Isatuximab"
                    },
                    {
                        "drugbank-id": "DB14824",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Icrucumab"
                    },
                    {
                        "drugbank-id": "DB14843",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Codrituzumab"
                    },
                    {
                        "drugbank-id": "DB14864",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Brolucizumab"
                    },
                    {
                        "drugbank-id": "DB14871",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Xentuzumab"
                    },
                    {
                        "drugbank-id": "DB14877",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lintuzumab"
                    },
                    {
                        "drugbank-id": "DB14891",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Vobarilizumab"
                    },
                    {
                        "drugbank-id": "DB14897",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Parsatuzumab"
                    },
                    {
                        "drugbank-id": "DB14905",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Emactuzumab"
                    },
                    {
                        "drugbank-id": "DB14907",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab zirconium Zr 89"
                    },
                    {
                        "drugbank-id": "DB14908",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Refanezumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB14947",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bermekimab"
                    },
                    {
                        "drugbank-id": "DB14952",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Pamrevlumab"
                    },
                    {
                        "drugbank-id": "DB14959",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Opicinumab"
                    },
                    {
                        "drugbank-id": "DB14962",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab deruxtecan"
                    },
                    {
                        "drugbank-id": "DB14967",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Margetuximab"
                    },
                    {
                        "drugbank-id": "DB14988",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Dalantercept"
                    },
                    {
                        "drugbank-id": "DB14997",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Pateclizumab"
                    },
                    {
                        "drugbank-id": "DB15014",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Gremubamab"
                    },
                    {
                        "drugbank-id": "DB15022",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Apomab"
                    },
                    {
                        "drugbank-id": "DB15044",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tafasitamab"
                    },
                    {
                        "drugbank-id": "DB15045",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ipafricept"
                    },
                    {
                        "drugbank-id": "DB15076",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Abrilumab"
                    },
                    {
                        "drugbank-id": "DB15089",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Frovocimab"
                    },
                    {
                        "drugbank-id": "DB15090",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tezepelumab"
                    },
                    {
                        "drugbank-id": "DB15101",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tigatuzumab"
                    },
                    {
                        "drugbank-id": "DB15104",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Telisotuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15113",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Utomilumab"
                    },
                    {
                        "drugbank-id": "DB15118",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Zolbetuximab"
                    },
                    {
                        "drugbank-id": "DB15135",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ponezumab"
                    },
                    {
                        "drugbank-id": "DB15160",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Asunercept"
                    },
                    {
                        "drugbank-id": "DB15172",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Suvratoxumab"
                    },
                    {
                        "drugbank-id": "DB15225",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Mitazalimab"
                    },
                    {
                        "drugbank-id": "DB15252",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Nemolizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB15277",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Gedivumab"
                    },
                    {
                        "drugbank-id": "DB15336",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Valanafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15349",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Sofituzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15354",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Evinacumab"
                    },
                    {
                        "drugbank-id": "DB15363",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Istiratumab"
                    },
                    {
                        "drugbank-id": "DB15383",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Pidilizumab"
                    },
                    {
                        "drugbank-id": "DB15397",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with GMA 161"
                    },
                    {
                        "drugbank-id": "DB15409",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Ladiratuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15415",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Tomaralimab"
                    },
                    {
                        "drugbank-id": "DB15428",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Vesencumab"
                    },
                    {
                        "drugbank-id": "DB15432",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Pinatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15441",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lulizumab pegol"
                    },
                    {
                        "drugbank-id": "DB15443",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Lorukafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15453",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Naratuximab emtansine"
                    },
                    {
                        "drugbank-id": "DB15559",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Zenocutuzumab"
                    },
                    {
                        "drugbank-id": "DB15898",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Atoltivimab"
                    },
                    {
                        "drugbank-id": "DB15899",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Maftivimab"
                    },
                    {
                        "drugbank-id": "DB15900",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Odesivimab"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Belantamab mafodotin"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The therapeutic efficacy of Calcium can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The therapeutic efficacy of Emicizumab can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14738",
                        "description": "The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00025",
                        "description": "The therapeutic efficacy of Antihemophilic factor human recombinant can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00036",
                        "description": "The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00100",
                        "description": "The therapeutic efficacy of Coagulation Factor IX Recombinant can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01783",
                        "description": "The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01942",
                        "description": "The therapeutic efficacy of Formic acid can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB02261",
                        "description": "The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09109",
                        "description": "The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09222",
                        "description": "The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09310",
                        "description": "The therapeutic efficacy of Catridecacog can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11168",
                        "description": "The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11311",
                        "description": "The therapeutic efficacy of Prothrombin can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11330",
                        "description": "The therapeutic efficacy of Factor IX Complex Human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11606",
                        "description": "The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11668",
                        "description": "The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12409",
                        "description": "The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12909",
                        "description": "The therapeutic efficacy of Factor XIII human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13133",
                        "description": "The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13148",
                        "description": "The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13150",
                        "description": "The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13151",
                        "description": "The therapeutic efficacy of Anti inhibitor coagulant complex can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13152",
                        "description": "The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13192",
                        "description": "The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13197",
                        "description": "The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13201",
                        "description": "The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13999",
                        "description": "The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14473",
                        "description": "The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14562",
                        "description": "The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The therapeutic efficacy of Calcium cation can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of hemorrhage can be increased when Seproxetine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of hemorrhage can be increased when Citalopram is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of hemorrhage can be increased when Duloxetine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of hemorrhage can be increased when Paroxetine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of hemorrhage can be increased when Sibutramine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hemorrhage can be increased when Nefazodone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of hemorrhage can be increased when Zimelidine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of hemorrhage can be increased when Milnacipran is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of hemorrhage can be increased when Indalpine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of hemorrhage can be increased when Ritanserin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of hemorrhage can be increased when Alaproclate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the antiplatelet activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB11268",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Protocatechualdehyde"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hemorrhage can be increased when Abciximab is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefotiam"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefmenoxime"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefmetazole"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefpiramide"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftazidime"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Loracarbef"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefalotin"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefotaxime"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefdinir"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cephalexin"
                    },
                    {
                        "drugbank-id": "DB00671",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefixime"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cephaloglycin"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefaclor"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceforanide"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefditoren"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefuroxime"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefapirin"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefadroxil"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefprozil"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftriaxone"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefamandole"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefazolin"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefonicid"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefoperazone"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefotetan"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefoxitin"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftizoxime"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefradine"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefepime"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefacetrile"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftibuten"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefpodoxime"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Latamoxef"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftobiprole"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftaroline fosamil"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefaloridine"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftolozane"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefminox"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefroxadine"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Flomoxef"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefatrizine"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefcapene"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefodizime"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefsulodin"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefetamet"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefbuperazone"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefozopran"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefpirome"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefazedone"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Ceftezole"
                    },
                    {
                        "drugbank-id": "DB14725",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefamandole nafate"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The risk or severity of bleeding can be increased when Doxycycline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of adverse effects can be increased when Azithromycin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09539",
                        "description": "The risk or severity of bleeding can be increased when Omega 3 acid ethyl esters is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may increase the antiplatelet activities of Abciximab"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of bleeding can be increased when Ibuprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of bleeding can be increased when Dexibuprofen is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01606",
                        "description": "The risk or severity of bleeding can be increased when Tazobactam is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of bleeding can be increased when Trazodone is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of bleeding can be increased when Escitalopram is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of bleeding can be increased when Sertraline is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB15258",
                        "description": "The therapeutic efficacy of Abciximab can be decreased when used in combination with Imlifidase"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}